Advertisement

Antimikrobielle Therapie

  • A. C. Rodloff

Zusammenfassung

Nach der Definition von Schottmüller aus dem Jahr 1914 ist die Sepsis ein Krankheitsbild, welches entsteht, wenn Infektionserreger aus einem lokalen Infektionsherd nach Durchbrechen der Abwehrmechanismen ständig oder intermittierend in die Blutbahn eingeschwemmt werden, zu systemischen Krankheitszeichen Anlaß geben und darüber hinaus u. U. weitere Infektionsherde ausbilden. Diese Definition ist auch von der Konsensuskonferenz 1992 [2] aufgenommen worden, die für die Definition der Sepsis neben den Zeichen des SIRS einen nachgewiesenen Infektionserreger fordert.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Abele-Horn M, Kopp A, Sternberg U et al. (1996) A randomized study comparing fluconazol with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 24: 426 - 432PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Grit Care Med 20: 864 - 874CrossRefGoogle Scholar
  3. 3.
    Baquero F (1996) Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J Antimicrob Chemother 38 (Suppl A): 117 - 132PubMedCrossRefGoogle Scholar
  4. 4.
    Cohen J, McConnel JS (1986) Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 5: 13 - 17PubMedCrossRefGoogle Scholar
  5. 5.
    Crosby H, Bion JF, Penn CW, Elliott TSJ (1994) Antibiotic-induced release of endotoxin from bacteria in vitro. J Med Microbiol 40: 23 - 30PubMedCrossRefGoogle Scholar
  6. 6.
    DIN 58940-1 (1995) Beuth-Verlag, BerlinGoogle Scholar
  7. 7.
    Ellner PD, Neu HC (1981) The inhibitory quotient. JAMA 246: 1575 - 1578Google Scholar
  8. 8.
    Eng RHK, Smith SM, Fan-Harvard P, Ogbara T (1993) Effect of antibiotics on endotoxin release from gramnegative bacteria. Diagn Microbiol Infect Dis 16: 185 - 189PubMedCrossRefGoogle Scholar
  9. 9.
    Gelfand JA, Elin RJ, Berry FW (1976) Endotoxemia associated with the Jarisch-Herxheimer reaction. N Engl J Med 295: 211 - 213PubMedCrossRefGoogle Scholar
  10. 10.
    Holzheimer RG, Hirte JF, Reith B et al. (1996) Different endotoxin release and Il-6 plasma levels after antibiotic administration in surgical intensive care patients. J Endotox Res 3: 261 - 267Google Scholar
  11. 11.
    Hurley JC (1995) Antibiotic-induced release of Endotoxin, a therapeutic paradox. Drug Safety 12: 183 - 195PubMedCrossRefGoogle Scholar
  12. 12.
    Jackson JJ, Kropp H (1992) 13-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 165: 1033 - 1041Google Scholar
  13. 13.
    Jones RN, Pfaller MA, Marshall SA, Hollis RJ, Wilke WW (1997) Antimicrobial activity against 270 nosocomial blood stream infection isolates caused by non-enteric gramnegative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Diagn Microbiol Infect Dis 29: 187-192Google Scholar
  14. 14.
    Kresken M, Hafner D (1996) Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa, 3. Aufl. EigenverlagGoogle Scholar
  15. 15.
    Norrby SR, Finch RG, Glauser M, and a European Study Group (1993) Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime vs. imipenem/cilastatin. J Antimicrob Chemother 31: 927 - 937CrossRefGoogle Scholar
  16. 16.
    Prins JM, van Agtmael MA, Kuijper ED, Deventer SJH, Speelmann P (1995) Antibiotic-induced endotoxin release in patients with gramnegative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 172: 886 - 891PubMedCrossRefGoogle Scholar
  17. 17.
    Reinert, RR, Queck A, Kaufhold A, Kresken M, Lütticken R (1995) Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994. Clin Infect Dis 21: 1398 - 1401PubMedCrossRefGoogle Scholar
  18. 18.
    Rex JH, Bennett JE, Sugar AM et al. (1994) A randomized trial comparing fluconacole with amphothericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331: 1325 - 1331PubMedCrossRefGoogle Scholar
  19. 19.
    Rosenthal EJK (1986) Septikämie-Erreger 1983-1985. Dtsch Med Wochenschr 111: 1874 - 1880PubMedCrossRefGoogle Scholar
  20. 20.
    Rosenthal EJK (1993) Epidemiologie von Septikämie-Erregern. Dtsch Med Wochenschr 118: 1269 - 1275PubMedCrossRefGoogle Scholar
  21. 21.
    Sandven P, Hoiby EA (1981) The importance of blood volume cultured on detection of Bacteraemia. Acta Pathol Microbiol Scand Sec B 89: 149 - 152Google Scholar
  22. 22.
    Simon C, Stille W (1997) Antibiotikatherapie in Klinik und Praxis. Schattauer, Stuttgart New YorkGoogle Scholar
  23. 23.
    Tauchnitz C, Handrick W (1989) Rationelle antimikrobielle Chemotherapie. J.A. Barth, LeipzigGoogle Scholar
  24. 24.
    Washington JA (1975) Blood cultures: Principles and techniques. Mayo Clin Proc 50: 91 - 98PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • A. C. Rodloff

There are no affiliations available

Personalised recommendations